Do rapid emotional thermometers correlate with multidimensional validated structured questionnaires in low-risk prostate cancer?

被引:1
|
作者
Laranja, Walker Wendell [1 ,2 ]
Pereira, Thairo Alves [1 ,2 ]
Guimaraes, Paulo Vitor Barreto [1 ,2 ]
Tobias-Machado, Marcos [1 ,2 ]
Leandro-Merhi, Vania Aparecida [1 ,2 ]
de Aquino, Jose Luis Braga [1 ,2 ]
Reis, Leonardo Oliveira [1 ,2 ]
机构
[1] Univ Estadual Campinas, UroScience, Campinas, SP, Brazil
[2] Pontifical Catholic Univ Campinas, Campinas, SP, Brazil
关键词
Prostate cancer; Emotional; Suffering; Thermometer; Questionnaire; HRQoL; DISTRESS THERMOMETER; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; QUALITY; SATISFACTION; DEPRESSION; BARRIERS; VERSION; BURDEN; INDEX;
D O I
10.1007/s11255-020-02399-w
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose To promptly identify mental suffering in low-risk prostate cancer (LRPC) patients, vulnerable to over- and undertreatment, we evaluated the correlation of rapid emotional thermometers (ET) with multidimensional validated structured questionnaires. Methods At diagnosis, consecutive LRPC patients underwent five ET domains: emotional suffering, anxiety, depression (DT), revolt and need for help and multidimensional questionnaires: beck anxiety inventory (BAI), beck depression inventory (BDI), beck hopelessness scale, SF36 (physical functioning PF, role limitations due to physical health RP, bodily pain BP, general health perceptions GH, vitality VT, social functioning SF, role limitations due to emotional problems RE and general mental health MH), international index of erectile function and international prostate symptom score (IPSS). Results Among 30 included patients, mean age 67.4 y (52-74), 20 days after the diagnosis (15-30), mean time to obtain ET 27 s (15-57) and all questionnaires 36.7 min (31-49), ETs showed moderate/strong Spearman correlation among themselves. DT domain displayed the best correlation to most of the multidimensional validated structured questionnaires: moderate to BDI, SF-36 (PF, GH, VT, SF, RE, MH) and IPSS and strong to BAI. Conclusion DT revealed the best correlation to validated structured questionnaires of diverse dimensions with clear potential for quick screening of patients with psychological suffering and in need of further evaluation and support.
引用
收藏
页码:1073 / 1078
页数:6
相关论文
共 50 条
  • [41] Active Surveillance for Low-Risk Prostate Cancer Reply
    Lellig, Katja
    Buchner, Alexander
    Stief, Christian
    UROLOGE, 2015, 54 (06): : 870 - 870
  • [42] Active surveillance for men with low-risk prostate cancer
    Sturch, Paul
    Kirby, Roger
    Challacombe, Ben
    TRENDS IN UROLOGY & MENS HEALTH, 2014, 5 (02) : 14 - 16
  • [43] Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer
    Choe, Kevin S.
    Liauw, Stanley L.
    THESCIENTIFICWORLDJOURNAL, 2010, 10 : 1854 - 1869
  • [44] Evolving Trends in the Management of Low-Risk Prostate Cancer
    Tzeng, Michael
    Basourakos, Spyridon P.
    Davuluri, Meenakshi
    Nagar, Himanshu
    Ramaswamy, Ashwin
    Cheng, Emily
    DeMeo, Gina
    Hu, Jim C.
    CLINICAL GENITOURINARY CANCER, 2022, 20 (05) : 423 - 430
  • [45] Active Surveillance for Low-Risk Localized Prostate Cancer
    Large, Michael C.
    Eggener, Scott E.
    ONCOLOGY-NEW YORK, 2009, 23 (11): : 974 - 979
  • [46] Dutasteride and active surveillance of low-risk prostate cancer
    Fleshner, Neil E.
    LANCET, 2012, 379 (9826): : 1590 - 1590
  • [47] Active surveillance for low-risk prostate cancer: an update
    Lawrentschuk, Nathan
    Klotz, Laurence
    NATURE REVIEWS UROLOGY, 2011, 8 (06) : 312 - 320
  • [48] Active surveillance for low-risk prostate cancer: an update
    Nathan Lawrentschuk
    Laurence Klotz
    Nature Reviews Urology, 2011, 8 : 312 - 320
  • [49] Low-risk Prostate Cancer: Identification, Management, and Outcomes
    Moschini, Marco
    Carroll, Peter R.
    Eggener, Scott E.
    Epstein, Jonathan I.
    Graefen, Markus
    Montironi, Rodolfo
    Parker, Christopher
    EUROPEAN UROLOGY, 2017, 72 (02) : 238 - 249
  • [50] THE IMPACT OF GENOMIC BIOMARKERS ON A VALIDATED CLINICAL RISK PREDICTION MODEL FOR UPGRADING/UPSTAGING AMONG MEN WITH LOW-RISK PROSTATE CANCER
    Braun, Avery
    Chan, June
    Neuhaus, John
    Cowan, Janet
    Kenfield, Stacey
    Van Blarigan, Erin
    Tenggara, Imelda
    Broering, Jeanette
    Simko, Jeff
    Cooperberg, Matthew
    Carroll, Peter
    JOURNAL OF UROLOGY, 2023, 209 : E523 - E524